ACUTE MYELOGENOUS LEUKEMIA AND AGING: Clinical Interactions
- 1 February 2000
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 14 (1) , 251-267
- https://doi.org/10.1016/s0889-8588(05)70287-2
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Cost‐effectiveness and quality‐of‐life assessment of GM‐CSF as an adjunct to intensive remission induction chemotherapy in elderly patients with acute myeloid leukaemiaBritish Journal of Haematology, 1998
- Validation of a model to predict survival in elderly patients with acute myeloid leukaemiaBritish Journal of Haematology, 1995
- Attenuated‐dose idarubicin in acute myeloid leukaemia of the elderly: pharmacokinetic study and clinical resultsBritish Journal of Haematology, 1995
- Acute myelogenous leukaemia in the elderly: retrospective study of 235 consecutive patientsBritish Journal of Haematology, 1994
- Acute myeloid leukemia in the elderly: biological features and search for adequate treatmentAnnals of Hematology, 1991
- Absence of correlation between cytotoxicity and drug transport by P‐glycoprotein in clinical leukemic cellsEuropean Journal of Haematology, 1991
- MDR1 transcript levels as an indication of resistant disease in acute myelogenous leukaemiaBritish Journal of Haematology, 1990
- Clonal Development, Stem-Cell Differentiation, and Clinical Remissions in Acute Nonlymphocytic LeukemiaNew England Journal of Medicine, 1987
- PRINCIPAL RESULTS OF THE MEDICAL RESEARCH COUNCIL'S 8th ACUTE MYELOID LEUKAEMIA TRIALThe Lancet, 1986
- Treatment of acute nonlymphocytic leukemia in elderly patients.A prospective study of intensive chemotherapyCancer, 1977